Chargement en cours...
Efficacy and safety of secukinumab in Chinese patients with moderate-to-severe plaque psoriasis: a real-life cohort study
BACKGROUND: There have been few real-life dose-comparing studies on the efficacy and safety of secukinumab in Chinese patients with plaque psoriasis. We conducted a real-life cohort study to investigate the efficacy and safety of secukinumab 150 and 300 mg in Chinese patients with moderate-to-severe...
Enregistré dans:
| Publié dans: | Chin Med J (Engl) |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Lippincott Williams & Wilkins
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8183798/ https://ncbi.nlm.nih.gov/pubmed/33950871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CM9.0000000000001510 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|